MedTrace Logo

This is a Study to Verify if Tranexamic Acid Can Reduce the Anemia After a Femoral Shaft Fractures Surgery

NCT04803591 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-10-13

No results posted yet for this study

Summary

The investigators are going to evaluate if adding Tranexamic Acid in femoral shaft fractures surgery can lead to any advantages to the participants, namely if it can reduce post-operative anaemia, blood loss, blood transfusion requirements, length and cost of hospitalisation.

Conditions

  • Femoral Shaft Fracture

Interventions

DRUG

Tranexamic Acid

Tranexamic Acid will be administered as an injectable solution (500mg/5ml or 1000mg/10ml).

Sponsors & Collaborators

  • Christian Candrian

    lead OTHER

Principal Investigators

  • Christian Candrian, MD; Prof. · EOC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2026-09-01
Completion
2026-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04803591 on ClinicalTrials.gov